Acetate metabolism in the mammary gland of lactating ewes was studied by continuous infusion of radioisotopic [U-14 C)sodium acetate and measurement of mammary gland arteriovenous difference and blood flow. Entry rate of acetate into the whole body averaged 75 ± 7 /Lmol min -I kg -I liveweight and 22' I ± 2 . 7 % of total C02 production was derived from acetate. Acetate was both utilized and produced by the mammary gland. Acetate uptake was related linearly (r2 = o· 94) to arterial concentration and gross utilization of acetate accounted for 16' 2 ± 2 . 6 % of whole-body entry rate. Endogenous acetate production by the mammary gland increased linearly (r2 = O· 90) as milk yield rose, and accounted for 25 . 6 ± 2 . 7 % of the gross mammary utilization of acetate. The proportion of mammary C02 derived from acetate (22' 5 ± 3' 9%) was similar to that of the whole body. The uptake of acetate, 3-hydroxybutyrate, esterified fatty acids and plasma free fatty acids accounted for about 25, 13, 60 and 4% of milk fatty acid carbon respectively, after correction for the oxidation of acetate, but not of the other substrates. Metabolism of acetate in the mammary glands of lactating ewes appears quantitatively more important than that in cows, b~t similar to that in goats.
Introduction
Acetate and 3-hydroxybutyrate taken up by the mammary gland of the goat are utilized for the de novo synthesis of the short-and medium-chain fatty acids, and for about half of the palmitate which appears in milk fat triacylglycerols (Annison 1984) . Ewes' milk has a higher fat content (Jenness 1974) and somewhat greater proportions of short-and medium-chain fatty acids in milk fat than in cow and goat milk fat (Christie 1978) , suggesting that at equivalent milk yields, the ewe mammary gland may use relatively more acetate and 3-hydroxybutyrate. Pethick and Lindsay (1982) showed that arterial concentrations and mammary extraction rates of acetate and 3-hydroxybutyrate in the ewe were similar to those reported for the goat and cow. Net use of acetate by the udder of the lactating ewe, in relation to whole-body utilization, was similar to that of goats, but higher than that of cows. In the absence of data on endogenous acetate production (see Annison 1984) and acetate oxidation, the actual contribution of acetate to milk fat synthesis could not be assessed, and further, the output and fatty acid composition of milk fat was not measured (Pethick and Lindsay 1982) .
In this study entry rate and oxidation of acetate in the whole animal and the production, oxidation and utilization of acetate in the mammary glands of lactating ewes were measured. In addition, the contributions of acetate, 3-hydroxybutyrate, plasma free fatty acids (FF A) and esterified fatty acids to milk fat synthesis are reported. Some of these results have been presented in a preliminary form (King et al. 1983 ).
Materials and Methods

Experimental Animals
Six multiparous crossbred ewes (Border Leicester x Merino), free from obvious abnormalities of the mammary glands, were housed indoors for at least 50 days before the start of the experiment. They were accustomed to handling so that blood sampling and hand milking (0830 and 1600 h daily) could be performed without restraint, and with minimum stress. Ewes were fed continuously a pelleted ration (45% lucerne hay, 40% crushed oats, 15% wheaten chaff (w/w), plus 1 % (w/w) sodium chloride; metabolizable energy (ME) 8·8 MJlkg dry matter; crude protein 179 g/kg dry matter; fatty acid content 25 g/kg dry matter) to calculated requirements for maintenance of liveweight and milk production (Anon. 1975) .
At the time of the experiment, milk yield, feed intake, liveweight and stage of lactation were 1·6 (mean) ± 0·17 (s.e.m.) kg/day, 16·9 ±0·68 MJ day/ME, 58 ± I ·9 kg and 32 ± 6·9 days, respectively.
Experimental Procedure
One week before the start of the experiment all ewes were fitted, under local anaesthesia, with an indwelling catheter (0·86 mm i.d., 1·27 mm o.d., Dural Plastics, Sydney) in a femoral artery via the saphenous artery. Two days before the experiment, catheters were inserted into a jugular vein and the medial subcutaneous mammary vein by the percutaneous Seldinger technique. Labelled [U)4Qsodium acetate (Amersham International; 37 kBq/ml, O· 1 mg/ml) in 0·9% (w/v) sterile sodium chloride was infused continuously (0·3 mllmin) for 7-9 h into four ewes in early lactation and two ewes in mid-lactation. Constant specific radioactivity (SRA) of circulating acetate was achieved after about 2-3 h. Four pairs of arterial and mammary venous blood samples were withdrawn simultaneously into heparinized syringes at 30-min intervals during the final 1 . 5 h of infusion and immediately cooled in crushed ice. A portion of blood was deproteinized and used to determine acetate and D( -)-3-hydroxybutyrate concentrations. Care was taken to ensure that blood acetate isolated by steam distillation was stored in the sodium form. The remaining blood was centrifuged at 4°C and the plasma stored at -16°C.
The transfer of radioactivity into milk fat during the infusion of labelled acetate was monitored in the two ewes studied in mid-lactation. Ewes were weighed weekly and hand-milked following the intravenous injection of 0 . 4 i.u. of Syntocinon (Sandoz, N .S. W., Australia) immediately after blood samples were taken. Milk samples (3 ml) were stored at -16°C.
Blood Analysis
Blood acetate concentration and specific radioactivity Acetate was isolated after steam distillation as the sodium salt from 3 ml of blood by the method of Annison (1954) . An aliquot was removed for scintillation counting on a Philips PW 4540 liquid scintillation analyser with external standard channels ratio for quench correction and a counting efficiency of 74%. The remainder of the sample was analysed for acetate concentration on a Varian 3700 gas-liquid chromatograph using isobutyric and isovaleric acids (British Drug Houses, Poole, England) as internal standards for calculation of concentration and amount of acetate counted, respectively. The sample was dissolved in 100 J.!I of formic acid (6·5 M) and 3 J.!I injected onto a 4 mm by 2 m glass column packed with Chromosorb 101 (Varian). Temperatures for the injector, detector and column were 200,250 and 145°C, respectively. Nitrogen gas flow was 25 mllmin. A removable glass pre-column insert (Varian) half-filled with Ballotini beads was used to reduce column contamination. Peak areas were measured using a computing integrator (SP 4100, Spectraphysics, California, U.S.A.). With this method the coefficient of variation associated with estimates (n = 8) of acetate concentration and radioactivity for a sample of pooled plasma were 6·1 and 7·1 %, respectively.
-3-Hydroxybutyrate concentration in blood was measured by the method of Zivin and Snarr (1973) .
Plasma free fatty acids
Plasma free fatty acids (FFA) determinations in plasma were by the method of Dole (1956) .
Glucose
Glucose concentration was measured in duplicate aliquots (100 J.!I) of the supernatant obtained by adding perchloric acid (I ·8 ml, 0·33 M) to plasma (0·2 ml). Glucose oxidase, peroxidase, 2,2' -azino-di-[3-ethylbenzthiazoline sulfonate] (ABTS, Boehringer, Mannheim, W. Germany) were mixed as described in the method of Bernt and Lachenicht (1974) . The absorbance was read at 675 nm.
Esterified fatty acids
Lipid was extracted from plasma by the method of Folch et al. (1957) after the addition of an internal standard (heptadecanoic acid; Sigma Chemical Co.). The isolated lipid was methylated with methanolic-HCI (Christie 1976 ) and total concentration of fatty acids determined by gas-liquid chromatography using a stainlesssteel column (2 m by 4 mm) containing 15% by weight EGSSX on Chromosorb P, 100-120 mesh (Applied SCience Laboratories, Pennsylvania, U.S.A.) at 170OC. Peak areas were measured by a computing integrator (SP 4100, Spectraphysics, California, U.S.A.). Because this method measured total plasma fatty acids, the concentration of esterified fatty acids (EF A) was calculated after correction for plasma FF A measured as described above.
Blood C02 specific radioactivity Blood C02 was isolated as BaC03 (Leng and Leonard 1965) and assayed for SRA using the modification of Hinks et al. (1966) . Distilled water (1 ·5 ml) and 12 ml of scintillation cocktail were added to the solubilized BaC03. External standard channels ratio was used for quench correction using a counting efficiency of 74%.
Blood gases
Blood was analysed within 30 min of collection on a 165/2 pH blood gas analyser (Corning, Massachusetts, U.S.A.). The pH and partial pressures of 02 and C02 were measured and the concentration of 02 and C02 calculated as described by Oddy et al. (1984) . Haemoglobin was determined using a colorimetric test kit (No. 124729, Boehringer Mannheim, W. Germany).
Milk and Feed Analyses
Milk Lipid was extracted from milk by the method of Folch et al. (1957) after the addition of an internal standard (triheptadecanoin, Nu-Chek-Prep, Inc., Minnesota, U.S.A.) and the fatty acids determined by gas-liquid chromatography by the method of Parodi (1970) .
Feed
Metabolizable energy was calculated from in vitro digestibility (Tilley and Terry 1963) and crude protein by multiplying the Kjeldahl nitrogen (%) by 6·25. Fatty acids were measured by gas-liquid chromatography after addition of an internal standard (heptadecanoic acid, Sigma Chemical Co.), using the direct methylation technique of Outen et al. (1976) .
Calculations
Acetate biokinetic data were calculated by the procedures (equilibrium method) outlined by Pethick et al. (1981) . All calculations of metabolite utilization by mammary tissue involved a blood flow estimate (ml/min) derived from the ratio of blood flow to milk yield of 487 (± 64) : I. This value was the average obtained in this laboratory from 15 lactating ewes in which mammary blood flow (millilitres per minute per 100 g) was measured using tritiated water (see Oddy et al. 1984) and mammary gland mass was measured after slaughter and dissection. Where uptake of a plasma metabolite was determined (e.g. FF A, EF A and glucose) blood flow was corrected to plasma flow by measuring packed cell volume and assuming that the metabolite was confmed to plasma.
Results
Acetate Metabolism
Whole animal The mean entry rate of acetate, and the proportion of CO2 derived from acetate are shown in Table I . Entry rate and the proportion of CO2 derived from acetate were not significantly (P > 0·05) related to milk yield, feed intake or arterial concentration.
Mammary gland
Data on acetate biokinetics in mammary tissue are given in Table I . Arterial concentration of blood acetate averaged I ·56 ± O· 10 mmolll and 60·0 ± 3 ·0% of the acetate was extracted by the mammary gland. The arteriovenous (A V) difference (mmol/l) was related to arterial concentration of acetate (AA, mmol/l) by the following equation:
Arteriovenous difference = -0 . S 9 + O· 98 (s.e. ± O· l3)AA ; r2 = 0'94, P < 0·01 .
The A V difference was not related to milk yield, butterfat yield or feed intake (P > O· OS).
The mammary glands both utilized and produced acetate (Table 1) . Gross and net utilization of acetate by the mammary glands accounted for, on average, 16·2 ±2·6% and 12· 3 ±2·l %, respectively, of whole-animal entry rate. Although there was no significant (P > O' OS) correlation between milk yield and gross or net utilization, the proportion of acetate entry rate used by the mammary gland appeared to increase as milk yield increased; the range in daily milk yield was 1 . 10 ± O' OS-2·26 ± 0 . 07 kg, with corresponding values of 8·3±0·2 and 21·O±0·S%, and 6·4±0·4 and 14·6 ± 1 . S % for gross and net utilization, respectively. Endogenous acetate production by the mammary glands comprised a constant proportion (2S -6 ± 2 . 7 %) of the gross mammary utilization of acetate and accounted for, on average, 3· 9% of whole-animal entry rate. The proportion of entry rate accounted for by endogenous production (%) in the mammary gland increased as milk yield, (Y, kg/day) increased, and the relationship was described by the following equation:
Endogenous production = -3 ·17 + 4·37 (s_e_ ± 0·73) Y; r2 = 0'90, P < 0·01 _ Oxidation accounted for 23·8 ± 5· 8% of the acetate used by the udder and the percentage of CO2 derived from the oxidation of acetate within the mammary gland was 22·5 ± 3· 9%, a value similar to that for the whole animal.
Mammary Metabolism of other Blood Metabolites
Arterial concentration and mammary A V differences for blood 3-hydroxybutyrate, plasma FF A, esterified fatty acids and glucose are given in Table 2 . Mean extraction rates for 3-hydroxybutyrate, plasma FF A, esterified fatty acids and glucose were 42'1±2'9, 1l·7±3·4, 12·4±1·4 and 30·1±3·0%, respectively. Table 2 . Arterial concentration (A; mM), mammary arteriovenous difference (A V; mM), extraction rate A (E; 0/0) and uptake (U, p.g C min -1 kg -1 Iiveweight) of circulating 3-hydroxybutyrate, plasma esterified fatty acids [expressed as palmitic and palmitoleic acids (P), stearic acids (S) and oleic acid (0) Esterified fatty acids of chain length C16-C18 which comprised 73% of the total fatty acids in arterial plasma were the major fraction contributing to the mammary uptake of long-chain fatty acids. The fatty acid composition of milk fat and production of milk fatty acids are shown in Table 3 . Those fatty acids synthesized de novo (i.e_ short-and medium-chain fatty acids, plus half of palmitic-assuming that lipogenesis from acetate is similar in goat and ewe mammary tissue) comprised about half of the total. After correction for the amount of acetate oxidized, but without correcting for the oxidation of the other substrates, all of the milk fat produced was accounted for by the uptake of acetate, 3-hydroxybutyrate, esterified fatty acids and plasma FF A: the contributions of each precursor to milk fat were 25· 4, 13· 2, 59· 9 and 4· 0%, respectively (Table 4) . Table 4 . Carbon balance (Ofo) for the production of milk fat in fed lactating ruminants Collated data for goat and cow from Linzell (1974) The uptake of acetate and 3-hydroxybutyrate, however, accounted for only 81 % of the milk fatty acids synthesized de novo (Table 5) , whereas the remaining milk fatty acids could be accounted for by uptake of their respective long-chain fatty acids from esterified fatty acids and plasma FF A. Entry rates of acetate in lactating ewes were similar to those reported for sheep (Oddy 1978; Pethick and Lindsay 1982) , and for lactating goats (Annison et al. 1967) and cows . Previous workers have established relationships between entry rate and both intake (fed or fasted) and arterial concentration of blood acetate (Annison et al. 1967; Pethick et al. 1981; Pethick and Lindsay 1982) . These relationships could not be examined in the present study because the sheep were fed to calculated requirements and intakes and arterial levels varied only over a limited range.
Discussion
The relationship found between arterial concentration and A V difference across the mammary gland is in agreement with earlier results (McClymont 1951; Linzell1960) , and consistent with the concept that circulating concentration is a major determinant of acetate utilization by peripheral tissues (see Bell 1980) . Although the mammary gland extracted a large proportion of arterial acetate, total utilization of acetate by the udder, expressed as a percentage of entry rate and for a mean milk yield of 1 . 62 litres per day, was only 16%. This value is similar to the value for net utilization of 17 % reported by Pethick and Lindsay (1982) for ewes producing 1 ·57 litres of milk per day. Values for net utilization in goats and cows are 20 ± 6 and 10 ± 4%, respectively , suggesting that utilization of acetate by the udder is similar for goats and sheep, and greater than that for the cow. Increased mammary utilization of acetate by the goat and sheep, relative to most cows, would be consistent with higher milk fat production (Jenness 1974) and increased proportions of milk fatty acids synthesized de novo in these species (Christie 1978) .
Data collated by Linzell (1974) for arterial concentration and mammary extraction and oxidation of the blood precursors of milk fat have been used to calculate a carbon balance for goats and cows (Table 4 ). The percentage of milk fatty acids synthesized de novo varies between species, and it would appear that only in the cow is the contribution of acetate and 3-hydroxybutyrate sufficient to account for the synthesis of the short-and medium-chain fatty acids (Table 5 ). Annison and Linzell (1964) showed that in goats, the uptake of acetate, after subtraction of the amount oxidized, accounted for 17-41 % of the fatty acids in milk, but three of the four animals had values between 17-29%. These data, and those obtained in the present study suggest that in the sheep and goat, there may be a shortfall of carbon for de novo synthesis of milk fatty acids.
A possible additional carbon source is lactate, which has been shown to be incorporated into lipids of ruminant adipose tissue (Prior 1978) and into milk fat by bovine (Rodriguez et al. 1983 ) and caprine mammary tissue (Baldner et al. 1982) .
When expressed as a percentage of entry rate, total utilization and endogenous production of acetate by the mammary gland increased as milk yield increased. There was no change in the extraction rate of arterial acetate (mean ± s.e.m., 60 ± 3%), or of the percentage of total utilization accounted for by endogenous production (25·6 ±2·7%).
The simultaneous uptake and release of acetate by many tissues is a puzzling phenomenon. The relationship between milk yield and endogenous acetate production shown here is the first reported correlation between level of metabolic activity and acetate production. This possibility was alluded to by Costa et al. (1976) . We have no explanation for the release of acetate by tissues beyond suggesting that the process allows acetate in excess of immediate requirements to be made available to other tissues.
